Unraveling LIS1-Lissencephaly: Insights from Cerebral Organoids Suggest Severity- Dependent Genotype-Phenotype Correlations, Molecular Mechanisms and Therapeutic Strategies

Archive ouverte

Zillich, Lea | Gasparotto, Matteo | Rossetti, Andrea Carlo | Fechtner, Olivia | Maillard, Camille | Hoffrichter, Anne | Zillich, Eric | Jabali, Ammar | Marsoner, Fabio | Artioli, Annasara | Wilkens, Ruven | Schroeter, Christina, B | Hentschel, Andreas | Witt, Stephanie | Melzer, Nico | Meuth, Sven, G | Ruck, Tobias | Koch, Philipp | Roos, Andreas | Bahi-Buisson, Nadia | Francis, Fiona | Ladewig, Julia

Edité par CCSD -

Lissencephaly is a developmental cortical malformation characterized by reduced to absent gyri and a disorganized cortex, often leading to severe impairments in affected individuals and a reduced life expectancy. Heterozygous mutations in the LIS1 gene, encoding a regulator of the microtubule motor dynein, cause lissencephaly with different clinical severities. While the clinical disease spectrum correlates with the degree of lissencephaly, location and type of mutation may not. We leveraged forebrain-type organoids from LIS1-lissencephaly patients, diagnosed with mild, moderate or severe lissencephaly to investigate, in a cytoarchitecture and multi-omics approach, how the severity degree in patients might relate to specific mutations in the LIS1 gene. We questioned which processes during cortical development might be differentially affected by severity grade, and whether they could be pharmacologically targeted. We found alterations in neurodevelopment often with a severity- dependent gradient. Specifically, we identified alterations of the cytoarchitecture, progenitor cell homeostasis and neurogenesis. Particularly important disease-linked molecular mechanisms were microtubule destabilization, WNT-signaling, and perturbed cadherin- and unfolded protein-binding. Some mechanisms exhibited a severity-dependent gradient, or were specific to a severe grade. We present strategies to reverse phenotypic changes in LIS1- patient organoids, and an in silico approach with therapeutic potential. Thus, we show that different LIS1-severity grades can be recapitulated in vitro , that there is a direct link between the phenotype and genotype, that organoid-based disease modeling can identify molecular underpinnings of malformations of cortical development and that organoids provide a valid platform to develop and test therapeutic strategies.

Suggestions

Du même auteur

Human cerebral organoids reveal progenitor pathology in EML1‐linked cortical malformation

Archive ouverte | Jabali, Ammar | CCSD

International audience. Malformations of human cortical development (MCD) can cause severe disabilities. The lack of human-specific models hampers our understanding of the molecular underpinnings of the intricate pr...

Mutations in the Heterotopia Gene Eml1/EML1 Severely Disrupt the Formation of Primary Cilia

Archive ouverte | Uzquiano, Ana | CCSD

International audience. Apical radial glia (aRGs) are predominant progenitors during corticogenesis. Perturbing their function leads to cortical malformations, including subcortical heterotopia (SH), characterized b...

Forebrain Eml1 depletion reveals early centrosomal dysfunction causing subcortical heterotopia

Archive ouverte | Zaidi, Donia | CCSD

International audience. Mechanisms leading to abnormal distribution of neural progenitors during cortical development in the context of subcortical heterotopia associated with EML1 mutations remain unknown. Using a ...

Chargement des enrichissements...